In a rare legal defeat, Bristol Myers Squibb and Sanofi fined $834M for 'deceptive marketing' on best-selling blood thinner Plavix
By the time the FDA slapped a black box warning on Plavix in 2010, the blockbuster blood thinner had been on the market for 13 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.